Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas P Hofer

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Cells|March 10, 2022
Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived SpheresEno I Essien, Thomas P Hofer, Michael J Atkinson, et al.
Cancer Letters|February 1, 2021
Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapyYanchun Ma, Vera Bauer, Tanja Riedel, et al.
Frontiers in Immunology|October 2, 2019
6-Sulfo LacNAc (Slan) as a Marker for Non-classical MonocytesThomas P Hofer, Arjan A van de Loosdrecht, Christiane Stahl-Hennig, et al.
Frontiers in Immunology|October 26, 2020
Subsets of CD1c<sup>+</sup> DCs: Dendritic Cell Versus Monocyte LineageLukas Heger, Thomas P Hofer, Venetia Bigley, et al.
Immunobiology|June 11, 2020
Epigenetics in non-classical monocytes support their pro-inflammatory gene expressionLu Zhang, Thomas P Hofer, Adam M Zawada, et al.
Radiation Oncology (London, England)|March 21, 2025
Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: a prospective explorative studyThomas P Hofer, Alexander E Nieto, Lukas Käsmann, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 23, 2014
Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosisThomas P Hofer, Marion Frankenberger, Irene Heimbeck, et al.
Cellular & Molecular Immunology|October 17, 2024
CD30 influences germinal center B-cell dynamics and the expansion of IgG1-switched B cellsYan Wang, Ursula Rambold, Petra Fiedler, et al.
Blood|October 8, 2015
slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutationThomas P Hofer, Adam M Zawada, Marion Frankenberger, et al.
Translational Lung Cancer Research|August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker studyLukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Cells|March 10, 2022
Combining HDAC and MEK Inhibitors with Radiation against Glioblastoma-Derived SpheresEno I Essien, Thomas P Hofer, Michael J Atkinson, et al.
Cancer Letters|February 1, 2021
Interleukin-10 counteracts T-helper type 1 responses in B-cell lymphoma and is a target for tumor immunotherapyYanchun Ma, Vera Bauer, Tanja Riedel, et al.
Frontiers in Immunology|October 2, 2019
6-Sulfo LacNAc (Slan) as a Marker for Non-classical MonocytesThomas P Hofer, Arjan A van de Loosdrecht, Christiane Stahl-Hennig, et al.
Frontiers in Immunology|October 26, 2020
Subsets of CD1c<sup>+</sup> DCs: Dendritic Cell Versus Monocyte LineageLukas Heger, Thomas P Hofer, Venetia Bigley, et al.
Immunobiology|June 11, 2020
Epigenetics in non-classical monocytes support their pro-inflammatory gene expressionLu Zhang, Thomas P Hofer, Adam M Zawada, et al.
Radiation Oncology (London, England)|March 21, 2025
Early recovery of leukocyte subsets is associated with favorable progression-free survival in patients with inoperable stage II/III NSCLC after multimodal treatment: a prospective explorative studyThomas P Hofer, Alexander E Nieto, Lukas Käsmann, et al.
Journal of Molecular Medicine (Berlin, Germany)|August 23, 2014
Decreased expression of HLA-DQ and HLA-DR on cells of the monocytic lineage in cystic fibrosisThomas P Hofer, Marion Frankenberger, Irene Heimbeck, et al.
Cellular & Molecular Immunology|October 17, 2024
CD30 influences germinal center B-cell dynamics and the expansion of IgG1-switched B cellsYan Wang, Ursula Rambold, Petra Fiedler, et al.
Blood|October 8, 2015
slan-defined subsets of CD16-positive monocytes: impact of granulomatous inflammation and M-CSF receptor mutationThomas P Hofer, Adam M Zawada, Marion Frankenberger, et al.
Translational Lung Cancer Research|August 12, 2022
Prospective evaluation of immunological, molecular-genetic, image-based and microbial analyses to characterize tumor response and control in patients with unresectable stage III NSCLC treated with concurrent chemoradiotherapy followed by consolidation therapy with durvalumab (PRECISION): protocol for a prospective longitudinal biomarker studyLukas Käsmann, Julian Taugner, Chukwuka Eze, et al.
Pageof 2